New immunotherapy shows complete responses in mantle cell lymphoma
Patients with a rare blood cancer that had relapsed or become resistant to treatment have shown a high response rate to a potent new immunotherapy drug, in a Peter Mac-led clinical trial.
The...Read more
5 October 2024